Contemporary Approach to Neurofibromatosis Type 1–Associated Malignant Peripheral Nerve Sheath Tumors
American Society of Clinical Oncology Educational Book · 2024-06 · 44 (3)
DOI: 10.1200/edbk_432242 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Society of Clinical Oncology Educational Book, 2024-06. Verfasst von Angela C Hirbe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology, Department of Medicine, Siteman Cancer Center, Barnes Jewish Hospital and Washington University School of Medicine, St Louis, M…. Hauptthemen laut MEDLINE: Neurofibromatosis 1, Nerve Sheath Neoplasms. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, Intramural NIH HHS.
Abstract (Originalsprache)
Most malignant peripheral nerve sheath tumors (MPNSTs) are clinically aggressive high-grade sarcomas, arising in individuals with neurofibromatosis type 1 (NF1) at a significantly elevated estimated lifetime frequency of 8%-13%. In the setting of NF1, MPNSTs arise from malignant transformation of benign plexiform neurofibroma and borderline atypical neurofibromas. Composed of neoplastic cells from the Schwannian lineage, these cancers recur in approximately 50% of individuals, and most patients die within five years of diagnosis, despite surgical resection, radiation, and chemotherapy. Treatment for metastatic disease is limited to cytotoxic chemotherapy and investigational clinical trials. In this article, we review the pathophysiology of this aggressive cancer and current approaches to surveillance and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Oncology, Department of Medicine, Siteman Cancer Center, Barnes Jewish Hospital and Washington University School of Medicine, St Louis, MO.
- Department of Anatomic Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN.
- Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
- Division of Oncology, Department of Medicine, University of Alabama, Birmingham, AL.
- Departments of Pathology & Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
ORCID-Profile: Angela C Hirbe
Förderung
- NIH HHS
- Intramural NIH HHS
Zitieren
APA
Hirbe, A. C., Dehner, C. A., Dombi, E., Eulo, V., Gross, A. M., Sundby, T., Lazar, A. J., & Widemann, B. C. (2024). Contemporary Approach to Neurofibromatosis Type 1–Associated Malignant Peripheral Nerve Sheath Tumors. American Society of Clinical Oncology Educational Book, 44(3). https://doi.org/10.1200/edbk_432242
Vancouver
Hirbe AC, Dehner CA, Dombi E, Eulo V, Gross AM, Sundby T, et al. Contemporary Approach to Neurofibromatosis Type 1–Associated Malignant Peripheral Nerve Sheath Tumors. American Society of Clinical Oncology Educational Book. 2024;44(3). doi:10.1200/edbk_432242
BibTeX
@article{Hirbe2024,
author = {Hirbe, Angela C and Dehner, Carina A and Dombi, Eva and Eulo, Vanessa and Gross, Andrea M and Sundby, Taylor and Lazar, Alexander J and Widemann, Brigitte C},
title = {Contemporary Approach to Neurofibromatosis Type 1–Associated Malignant Peripheral Nerve Sheath Tumors},
journal = {American Society of Clinical Oncology Educational Book},
year = {2024},
volume = {44},
number = {3},
doi = {10.1200/edbk_432242}
}
EUVIMED